Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neural Correlates of an Olive Oil Essence

This study has been completed.
Sponsor:
Collaborators:
German Research Foundation
German Federation of Industrial Research Associations
Zentrum für Ernährungsmedizin und Prävention
German Center for Diabetes Research
University of Hohenheim
Ludwig-Maximilians - University of Munich
Information provided by (Responsible Party):
Sabine Frank, University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT01716286
First received: October 18, 2012
Last updated: May 10, 2016
Last verified: May 2016
  Purpose
The aim of the current study was to investigate the effect of a low fat meal in comparison to a low fat meal dosed with the fatfree essence of olive oil.

Condition Intervention
Neural Correlated of Different Foods
Dietary Supplement: low fat vs. essence yoghurt

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science

Further study details as provided by University Hospital Tuebingen:

Primary Outcome Measures:
  • change in brain activity (cerebral blood flow change after yogurt intake) [ Time Frame: 30 minutes before as well as 30 minutes and 120 minutes after yoghurt intake ] [ Designated as safety issue: No ]

Enrollment: 11
Study Start Date: February 2012
Study Completion Date: March 2012
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: yoghurt type
low fat yoghurt vs. essence yoghurt
Dietary Supplement: low fat vs. essence yoghurt

  Eligibility

Ages Eligible for Study:   20 Years to 33 Years   (Adult)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • male
  • heatly

Exclusion Criteria:

  • lactose intolerance
  • fMRI cotraindications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01716286

Locations
Germany
University Clinic of Tuebingen, MEG Center
Tuebingen, Germany, 72076
Sponsors and Collaborators
University Hospital Tuebingen
German Research Foundation
German Federation of Industrial Research Associations
Zentrum für Ernährungsmedizin und Prävention
German Center for Diabetes Research
University of Hohenheim
Ludwig-Maximilians - University of Munich
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Sabine Frank, Principal Investigator, University Hospital Tuebingen
ClinicalTrials.gov Identifier: NCT01716286     History of Changes
Other Study ID Numbers: YOG2 
Study First Received: October 18, 2012
Last Updated: May 10, 2016
Health Authority: Germany: Ethics Commission

ClinicalTrials.gov processed this record on September 26, 2016